Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Olive

Showing results (191-200 of 276) with videos related to

Pageof 28
Sort By:
Frontiers in Immunology|March 15, 2018
The MEK1/2-ERK Pathway Inhibits Type I IFN Production in Plasmacytoid Dendritic CellsVaclav Janovec, Besma Aouar, Albert Font-Haro, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|July 22, 2014
Membrane expression of NK receptors CD160 and CD158k contributes to delineate a unique CD4+ T-lymphocyte subset in normal and mycosis fungoides skinNouhoum Sako, Valérie Schiavon, Touda Bounfour, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 29, 2012
B and T lymphocyte attenuator mediates inhibition of tumor-reactive CD8+ T cells in patients after allogeneic stem cell transplantationWillemijn Hobo, Wieger J Norde, Nicolaas Schaap, et al.
European Journal of Medicinal Chemistry|February 23, 2018
Enediynes bearing polyfluoroaryl sulfoxide as new antiproliferative agents with dual targeting of microtubules and DNACyril Borie, Shovan Mondal, Tanzeel Arif, et al.
Oncoimmunology|November 18, 2016
BTN3A molecules considerably improve Vγ9Vδ2T cells-based immunotherapy in acute myeloid leukemiaAudrey Benyamine, Aude Le Roy, Emilie Mamessier, et al.
Oncotarget|September 24, 2016
PD-1 mediates functional exhaustion of activated NK cells in patients with Kaposi sarcomaAsma Beldi-Ferchiou, Marion Lambert, Stéphanie Dogniaux, et al.
Oncoimmunology|November 12, 2020
Baseline plasma levels of soluble PD-1, PD-L1, and BTN3A1 predict response to nivolumab treatment in patients with metastatic renal cell carcinoma: a step toward a biomarker for therapeutic decisionsLorena Incorvaia, Daniele Fanale, Giuseppe Badalamenti, et al.
Human Immunology|February 19, 2004
Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL functionGilberto Filaci, Marco Fravega, Simone Negrini, et al.
Blood Advances|March 31, 2021
Functional characterization of PD1+TIM3+ tumor-infiltrating T cells in DLBCL and effects of PD1 or TIM3 blockadeMikaël Roussel, Kieu-Suong Le, Clémence Granier, et al.
The Journal of Infectious Diseases|January 25, 2021
Monocytes and Macrophages, Targets of Severe Acute Respiratory Syndrome Coronavirus 2: The Clue for Coronavirus Disease 2019 ImmunoparalysisAsma Boumaza, Laetitia Gay, Soraya Mezouar, et al.
Pageof 28

Showing results (191-200 of 276) with videos related to

Sort By:
Pageof 28
Frontiers in Immunology|March 15, 2018
The MEK1/2-ERK Pathway Inhibits Type I IFN Production in Plasmacytoid Dendritic CellsVaclav Janovec, Besma Aouar, Albert Font-Haro, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|July 22, 2014
Membrane expression of NK receptors CD160 and CD158k contributes to delineate a unique CD4+ T-lymphocyte subset in normal and mycosis fungoides skinNouhoum Sako, Valérie Schiavon, Touda Bounfour, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 29, 2012
B and T lymphocyte attenuator mediates inhibition of tumor-reactive CD8+ T cells in patients after allogeneic stem cell transplantationWillemijn Hobo, Wieger J Norde, Nicolaas Schaap, et al.
European Journal of Medicinal Chemistry|February 23, 2018
Enediynes bearing polyfluoroaryl sulfoxide as new antiproliferative agents with dual targeting of microtubules and DNACyril Borie, Shovan Mondal, Tanzeel Arif, et al.
Oncoimmunology|November 18, 2016
BTN3A molecules considerably improve Vγ9Vδ2T cells-based immunotherapy in acute myeloid leukemiaAudrey Benyamine, Aude Le Roy, Emilie Mamessier, et al.
Oncotarget|September 24, 2016
PD-1 mediates functional exhaustion of activated NK cells in patients with Kaposi sarcomaAsma Beldi-Ferchiou, Marion Lambert, Stéphanie Dogniaux, et al.
Oncoimmunology|November 12, 2020
Baseline plasma levels of soluble PD-1, PD-L1, and BTN3A1 predict response to nivolumab treatment in patients with metastatic renal cell carcinoma: a step toward a biomarker for therapeutic decisionsLorena Incorvaia, Daniele Fanale, Giuseppe Badalamenti, et al.
Human Immunology|February 19, 2004
Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL functionGilberto Filaci, Marco Fravega, Simone Negrini, et al.
Blood Advances|March 31, 2021
Functional characterization of PD1+TIM3+ tumor-infiltrating T cells in DLBCL and effects of PD1 or TIM3 blockadeMikaël Roussel, Kieu-Suong Le, Clémence Granier, et al.
The Journal of Infectious Diseases|January 25, 2021
Monocytes and Macrophages, Targets of Severe Acute Respiratory Syndrome Coronavirus 2: The Clue for Coronavirus Disease 2019 ImmunoparalysisAsma Boumaza, Laetitia Gay, Soraya Mezouar, et al.
Pageof 28